The Syracuse Lowell Smith Walk to Defeat ALS will take place on Saturday, Aug. 29 at Long Branch Park in Liverpool at 10 a.m. Interested parties can sign up to participate at the event or as a virtual walker by going to www.walktodefeatals.org.
In last year's walk, over 300 walkers raised more than $70,000 for cutting-edge research and vital patient services. The ALS Association is funded solely by donations and all services to patients are offered free of charge. This year's sponsors include presenting sponsors Dairylea Cooperative Inc. and the Lowell Smith Circle of Courage, as well as Entergy Nuclear, CNA Foundation, Kinney Drugs Foundation, Wegmans and Welch Allyn.
Amyotrophic lateral sclerosis (ALS), more commonly referred to as Lou Gehrig's disease, is a progressive neurodegenerative disease that attacks nerve cells and pathways in the brain and spinal cord. When these cells die, voluntary muscle control and movement dies with them. Patients in the later stages of the disease are totally paralyzed, yet in most cases, their minds remain sharp and alert. The average life expectancy of a person with ALS is two to five years from time of diagnosis.
With recent advances in research and improved medical care, many patients are living longer, more productive lives. Half of all those affected live at least three years or more after diagnosis. About 20 percent live five years or more, and up to ten percent will survive more than ten years.
ALS occurs throughout the world with no racial, ethnic, or socioeconomic boundaries. ALS can strike anyone. Every single American is threatened by this disease.
About Walk to Defeat ALS:
The Walk to Defeat ALS' is The ALS Association's National Signature Event and the largest ALS fundraising event in the United States. The primary objective of the Walk to Defeat ALS' is to generate funds to increase funding for our National Research Program and to increase the Association's capacity to provide compassionate care and services to those diagnosed with ALS. The Walk to Defeat ALS' is one of the most cost-efficient events in the United States with $0.91 of every $1 going to support research and patient services.